ABSTRACT -Cytochrome P450(CYP)s are known to show a sexual dimorphic expression in rat livers. However, the comprehensive analysis for the sex-dependent gene expressions of drug metabolizing enzymes except for CYPs, transporters and nuclear receptors in rat livers and kidneys has not been investigated yet. The purpose of the present study was to identify the novel drug metabolizing and pharmacokinetics (DMPK)-related gene(s) which show the sex difference in the mRNA expressions in rat livers and kidneys. Total RNAs were prepared from livers and kidneys in both male and female rats (Crl:CD(SD) and Crlj:WI). A DNA microarray analysis using a "GeneSQUARE Multiple Assay DNA Microarray Drug Metabolism Gene Expression for Rat" was performed. DMPK-related genes which showed sex differences in the mRNA expression were identified in rat livers or kidneys. Especially, the female dominant expressions of UDP glucuronosyltransferase (UGT) s were seen in rat livers and kidneys. The sex difference of UGT expressions in rats might be one of the causal factors of the sex difference of the biological response to UGT substrates.
INTRODUCTION
Sex-related differences in the toxic susceptibility of rats have been documented for industrial chemicals (Muraoka and Itoh, 1980) , environmental pollutants (Knuckles et al., 2004) , insecticides (Carlson and DuBois, 1970; Agarwal et al., 1982) and pharmaceuticals (McGovren et al., 1981; Coleman et al., 1990; Wang et al., 2001; Stern et al., 2007) . The susceptibility of male rats to acetaminophen-induced hepatotoxicity is higher than that of female rats (Raheja et al., 1983) . Male rats are more sensitive to the nephrotoxicity induced by hexachlorobenzene than are female rats (Bouthillier et al., 1991) .
The sex divergence of drug-metabolizing enzymes thought to be one of the causal factors responsible for the sex differences of pharmacokinetics and toxicity (Anderson, 2005; Tran et al., 1998) . The metabolisms of many drugs including barbiturates and steroids are known to show marked sex differences in mice and rats (Nicholas and Barron, 1932; Kato, 1974; Skett, 1988 ).
These differences in drug metabolism have been reported to be attributed to the sex-divergent gene expressions of drug-metabolizing enzymes including cytochrome P450 (CYP)s (Shapiro et al., 1995) . However, the comprehensive analysis for the sex-dependent gene expressions of drug metabolizing enzymes except for CYPs, transporters and nuclear receptors in rat livers and kidneys has not been investigated yet.
In the present study, we identified novel drug metabolizing and pharmacokinetics (DMPK)-related gene(s) which show the sex difference of the mRNA expressions in rat livers and kidneys using a DNA microarray "GeneS-QUARE Multiple Assay DNA Microarray Drug Metabolism Gene Expression for Rat" (http://www.kurabo.co.jp/ nbd/array/rat.html).
MATERIALS AND METHODS

Animals
Five male and five female rats (Crl:CD(SD) and 
RNA isolation
Total RNA was prepared from the rat livers and kidneys using RNeasy Plus Mini (QIAGEN) according to the manufacturer's instructions. The quality of the purified total RNA was analyzed with a Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA). The criterion for the use of a sample was that the ribosomal RNA ratio of 18s to 28s be two or more. Total RNA (3.0 μg) prepared from the same sex and aged group (n = 5) were pooled for DNA microarray analysis.
Microarray
Total RNA (10 μg) were reverse-transcribed in the presence of SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA), Cy3-dUTP (GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK), oligo(dT)12-18prim-er (Invitrogen) and RNase Inhibitor (Toyobo, Osaka, Japan) in buffer consisting of 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM dithiothreitol, and deoxynucleoside 5'-triphosphates. Reactions were each carried out at 42°C for 80 min, with an addition of SuperScript II Reverse Transcriptase 40 min after start. The resulting Cy3-labeled cDNA probes were purified with MinElute PCR Purification Kit (QIAGEN) according to the manufacturer's protocol.
GeneSQUARE Multiple Assay DNA Microarray Drug Metabolism Gene Expression for Rat (Kurabo Industries Ltd., Osaka, Japan) was used in gene expression analysis. The microarray slides were first pretreated with blocking solution consisting of 4 × standard saline citrate (SSC), 0.5% SDS, and 1% bovine serum albumin at 42°C for 45 min. The labeled cDNA in hybridization buffer [consisting of 2 × SSC, 4 × Denhardt's solution (Sigma-Aldrich, St. Louis, MO, USA) and salmon sperm DNA (Invitrogen)] were denatured at 95°C for 2 min and cooled to room temperature. Then, cDNA were applied to each individual array window and hybridized at 65°C for 16 hr. After hybridization, the solutions of labeled cDNA on the microarray slides were flushed away by a solution containing 2 × SSC and 0.1% SDS, and then the microarray slide was immediately washed in following solutions; 2 × SSC and 0.1% SDS at room temperature for 5 min, 0.2 × SSC and 0.1% SDS at room temperature for 5 min, 0.2 × SSC and 0.1% SDS at 55°C for 5 min, 0.2 × SSC at room temperature for 1 min and 0.05 × SSC at room temperature for 2 min. The images for the hybridized array was captured by GenePix 4000B microarray scanner (Molecular Devices, Sunnyvale, CA, USA) and quantified by using the Genepix Pro 6.0 software (Molecular Devices). The adjusted intensity equals the intensity of each gene minus the background value. The genes with an adjusted intensity of less than 2-fold the background value were not detected. The normalized intensity to GAPDH gene were calculated by the following formula and compared with other treatment: normalized intensity = (X-Z)/(Y-Z) × 103, where X is the adjusted intensity of target gene, Y is the adjusted intensity of GAPDH gene, and Z is the median of adjusted intensities of the negative controls. To obtain a global view of sex-related changes in gene expressions, a cluster analysis was performed on signal log ratios with Cluster developed by Eisen (Eisen et al., 1998) .
RESULTS AND DISCUSSION
To identify the genes which show the sex-dependent gene expression of drug metabolizing enzymes, transporters and nuclear receptors in rat livers, a DNA microarray and a cluster analysis were performed (Fig. 1) . Cyp2c11, Cyp2a2, Cyp2c13, Sult1e1, Sult1c3, Gstm3 and Slc10a2 genes in the 114 DMPK-related genes were identified as a cluster which showed the male-predominant gene expressions in the rat livers (Fig. 1A and Table 1A) . Cyp2c11, Cyp2a2, Cyp2c13 and Sult1c3 genes were reported to be expressed predominantly in the male rat livers Yamazoe et al., 1986; Waxman et al., 1988; Nagata et al., 1993) . Sult1e1, Gstm3 and Slc10a2 (ASBT) genes were the novel genes which showed the male-predominant gene expressions in the rat livers. Cyp2c12, Cyp2a1, Ahr, Ugt1a8, Cyp2e1, Ugt1a2, Gsta3, Cyp2c6, Cyp4a1, Ugt1a9, Sult2a1, Slco1a6 and Slc22a5 genes were identified as a cluster which showed the female-predominant gene expressions in the rat livers ( Fig. 1B and Table 1B ). It has been reported that Cyp2c12, Cyp2a1, Gsta3 and Sult2a1 genes were expressed predominantly in the male rat livers Pampori and Shapiro, 1996; Meinl et al., 2009; Ahluwalia et al., 2004) . Ahr, Ugt1a8, Cyp2e1, Ugt1a2, Cyp2c6, Cyp4a1, Ugt1a9, Slco1a6 and Slc22a5 were the novel genes which showed the female-predominant gene expressions in the rat livers.
To identify the genes which show the sex-divergent gene expression in rat kidneys, a DNA microarray and a cluster analysis were also performed shown in Fig. 2 and Table 2 . Cyp2c6, Cyp2d4, Slc22a6 (Oat1), Cyp2c12, Cyp2c11, Cyp2d5, Cyp2d1, Slco1a1 (Oatp1), Slc22a2 (OCT2) and Slc21a4 (OAT-K1) genes in the 114 genes showed the male-predominant gene expressions in the rat kidneys ( Fig. 2A and Table 2A ). Slc22a6 (Oat1) and Slc22a2 (OCT2) genes were reported to show the male dominant expressions in the rat kidneys (Buist and Klaassen, 2004; Urakami et al., 1999). Cyp2c6, Cyp2d4, Cyp2c12, Cyp2c11, Cyp2d5, Cyp2d1, Slco1a1 (Oatp1) and Slc21a4 (OAT-K1) genes were the novel genes which showed the male-predominant gene expressions in rat kidneys. Ugt1a6, Ugt1a7c, Ugt1a8, Cyp4b1, Ugt1a9, Abcb1b, Abcc1, Ahr and Slc22a7 (Oat2) genes showed the female-predominant gene expressions in the kidneys in both strain adult rats (Fig. 2B and Table 2B ). It was reported that Slc22a7 gene was expressed predominantly in the male rat kidneys (Buist and Klaassen, 2004) . Buist et al., 2004 Ugt1a6, Ugt1a7c, Ugt1a8, Cyp4b1, Ugt1a9, Abcb1b, Abcc1 and Ahr genes were the novel genes which show the female-predominant gene expressions in the rat kidneys.
In the present study, we identified several genes which showed sexual dimorphic expressions in the rat livers and kidneys. These sexual dimorphic expressions were observed in both strains (Crl:CD(SD) and Crlj:WI), suggesting that the sex-dependent expressions might not be a strain-specific phenomenon. In this study, several genes which showed sexual dimorphic expressions in the 8 week rat livers and kidneys, but not in the 3 week rat livers and kidneys were identified. It has been reported that growth hormone (GH) exerts sex-dependent effects on the liver in rats, with many hepatic genes, most notably genes coding for CYP enzymes, being transcribed in a sex-dependent manner (Shapiro et al., 1995) . Thus, it is possible to assume that the identified genes to show sexual dimorphic expressions in the adult rat livers are regulated by a GHregulated transcription factor including signal transducers and activators of transcription 5. The female dominant expressions of UDP glucuronosyltransferase (UGT) s and aryl hydrocarbon receptor (AhR) are observed in adult rat livers and kidneys. The gene expressions of UGT1 family were reported to be regulated by AhR (Bock and Bock-Hennig, 2010) . Together with these results, it may be possible that the sex-divergent gene expressions of UGTs are caused by the female dominant expression of AhR. Raheja et al. (1983) reported that the extent of hepatic damage induced by acetaminophen in the male rats was greater than in the female rats and the concentration of the acetaminophen glucuronide conjugate was significantly higher in the female than it was in the male rats. We showed that the UGT genes were expressed predominantly in the female rat livers and kidneys, suggesting that the sex-related difference in acetaminophen toxicity might come from such variation in UGT expressions.
